According to a new survey by Validic of 166 executives at pharma and biotech companies, contract research organizations, and others in the clinical trial space, 64 percent have used digital technologies in clinical trials, and 97 percent plan to in the next five years. The survey was presented at DPharm Disruptive Innovations US in Boston.

Read the source article at MobiHealthNews